| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |